Multicenter Analysis of Attrition from the Pediatric Tuberculosis Infection Care Cascade in Boston.
care cascade
interferon gamma release assay
latent tuberculosis
pediatric
tuberculin
Journal
The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
22
03
2022
revised:
12
08
2022
accepted:
23
09
2022
pubmed:
2
10
2022
medline:
22
3
2023
entrez:
1
10
2022
Statut:
ppublish
Résumé
To characterize losses from the pediatric tuberculosis (TB) infection care cascade to identify ways to improve TB infection care delivery. We conducted a retrospective cohort study of children (age <18 years) screened for TB within 2 Boston-area health systems between January 2017 and May 2019. Patients who received a tuberculin skin test (TST) and/or an interferon gamma release assay (IGRA) were included. We included 13 353 tests among 11 622 patients; 93.9% of the tests were completed. Of 199 patients with positive tests for whom TB infection evaluation was clinically appropriate, 59.3% completed treatment or were recommended to not start treatment. Age 12-17 years (vs < 5 years; aOR 1.59; 95% CI, 1.32-1.92), non-English/non-Spanish language preference (vs English; aOR, 1.34; 95% CI, 1.02-1.76), and receipt of an IGRA (vs TST, aOR, 30.82; 95% CI, 21.92-43.34) were associated with increased odds of testing completion. Odds of testing completion decreased as census tract social vulnerability index quartile increased (ie, social vulnerability worsened; most vulnerable quartile vs least vulnerable quartile, aOR, 0.77; 95% CI, 0.60-0.99). Odds of completing treatment after starting treatment were higher in females (vs males; aOR, 2.35; 95% CI, 1.14-4.85) and were lower in patients starting treatment in a primary care clinic (vs TB/infectious diseases clinic; aOR, 0.44; 95% CI, 0.27-0.71). Among children with a high proportion of negative TB infection tests, completion of testing was high, but completion of evaluation and treatment was moderate. Transitions toward IGRA testing will improve testing completion; interventions addressing social determinants of health are important to improve treatment completion.
Identifiants
pubmed: 36181869
pii: S0022-3476(22)00860-5
doi: 10.1016/j.jpeds.2022.09.038
pmc: PMC10334304
mid: NIHMS1914951
pii:
doi:
Types de publication
Multicenter Study
Journal Article
Research Support, U.S. Gov't, P.H.S.
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
181-188.e5Subventions
Organisme : NIMH NIH HHS
ID : K24 MH114732
Pays : United States
Organisme : AHRQ HHS
ID : T32 HS000063
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
Lancet Infect Dis. 2016 Nov;16(11):1269-1278
pubmed: 27522233
Eur Respir J. 2020 Mar 20;55(3):
pubmed: 31980498
Clin Infect Dis. 2022 Nov 14;75(10):1792-1799
pubmed: 35363249
J Environ Health. 2018 Jun;80(10):34-36
pubmed: 32327766
Am J Respir Crit Care Med. 2016 Aug 15;194(4):501-9
pubmed: 26866439
Lancet. 2019 May 25;393(10186):2168-2174
pubmed: 30981536
Geospat Health. 2011 May;5(2):265-73
pubmed: 21590677
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):610-623
pubmed: 28482955
Int J Infect Dis. 2014 Jun;23:4-7
pubmed: 24657274
Ann Surg Oncol. 2021 Apr;28(4):1918-1926
pubmed: 33057860
PLoS Med. 2019 Feb 27;16(2):e1002754
pubmed: 30811385
PLoS One. 2017 Aug 1;12(8):e0182185
pubmed: 28763500
Int J Tuberc Lung Dis. 2015 Jul;19(7):799-804
pubmed: 26056104
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
Clin Infect Dis. 2021 Nov 2;73(9):e3531-e3535
pubmed: 33242078
BMC Infect Dis. 2020 May 18;20(1):352
pubmed: 32423422
BMC Public Health. 2017 Jun 2;17(1):538
pubmed: 28578689
Health Policy Plan. 2020 Oct 1;35(8):1130-1132
pubmed: 32832996
Am J Public Health. 2018 Nov;108(S4):S242-S245
pubmed: 30383424
BMJ Glob Health. 2021 May;6(5):
pubmed: 34016576
Clin Infect Dis. 2017 Jan 15;64(2):111-115
pubmed: 28052967
Matern Child Health J. 2006 Mar;10(2):171-6
pubmed: 16496221
PLoS One. 2020 Dec 3;15(12):e0243102
pubmed: 33270737
PLoS One. 2021 Apr 1;16(4):e0249012
pubmed: 33793612
Surgery. 2021 Aug;170(2):571-578
pubmed: 33775393
Pediatrics. 2019 Jun;143(6):
pubmed: 31147487
J Infect Public Health. 2010;3(2):67-75
pubmed: 20701894
Pediatr Clin North Am. 2017 Aug;64(4):893-909
pubmed: 28734517
J Pediatr. 2015 May;166(5):1240-1245.e1
pubmed: 25720366
Int J Tuberc Lung Dis. 2014 Jun;18(6):640-6
pubmed: 24903932
Pediatrics. 1997 Aug;100(2 Pt 1):210-3
pubmed: 9240801
MMWR Recomm Rep. 2020 Feb 14;69(1):1-11
pubmed: 32053584
Pediatrics. 2020 Jan;145(1):
pubmed: 31892521
J Surg Res. 2019 Nov;243:160-164
pubmed: 31177035
Int J Tuberc Lung Dis. 2014 Dec;18(12):1449-54
pubmed: 25517810
Eur Respir J. 2018 Jul 11;52(1):
pubmed: 29748305
Eur Respir J. 2019 Sep 12;54(3):
pubmed: 31221810